Skopos Labs, Inc. Novo Cure LTD Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Skopos Labs, Inc. holds 2,895 shares of NVCR stock, worth $32,829. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,895
Previous 2,895
-0.0%
Holding current value
$32,829
Previous $51,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NVCR
# of Institutions
271Shares Held
73.5MCall Options Held
971KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$138 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$122 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$72.4 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$62.6 Million8.14% of portfolio
-
State Street Corp Boston, MA2.59MShares$29.4 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.19B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...